Health13 hours ago
European Medicines Agency Endorses Alvotech’s Gobivaz® for Approval
The European Medicines Agency (EMA) has moved forward with a positive recommendation for Gobivaz®, a proposed biosimilar to Simponi® (golimumab), developed by Alvotech, a biotechnology firm...
